Harrisons Fund
Donate YouTube Instagram Twitter Facebook
NEWS   |   CONTACT

Solid Biosciences receives $50M investment!

31 Mar 2017

Exciting news as Solid Biosciences receives $50M investment on Thursday led by RA Capital Management and Bain Capital's new life sciences fund.
"The announcement marks the first investment closed by  Bain Capital Life Sciences, a recently-formed fund, led by former Biogen executive Adam Koppel. Solid is developing gene therapy treatments for Duchenne muscular dystrophy. One of several biotechs focused on Duchenne, Ilan Ganot launched Solid after his son was diagnosed with Duchenne. "Solid is hoping to use gene therapy technology to insert a corrected version of the dystrophin gene. Solid said that it planned to use the $50 million investment to advance its lead drug into the clinic in the second half of this year, and to boost its manufacturing capabilities."  - Boston Business Journal, Mar 30, 2017, 9:54am EDT.

To read the full story: http://www.bizjournals.com/boston/news/2017/03/30/biogen-backed-duchenne-firm-solid-biosciences.html

Test tubes, Photo credit: Fox News

categories

General

archive

2016   2015   2014   2013  

see our latest video

tweety-pie

COPYRIGHT 2014 HARRISON’S FUND
ALL RIGHTS RESERVED | REGISTERED UK CHARITY NO. 1146662
SITE BY MZURI DESIGN